education session her2 breast cancer updates from the clinic and the lab
Published 4 months ago • 170 plays • Length 1:42:44Download video MP4
Download video MP3
Similar videos
-
23:31
education sessions: "the ideal partner to her2 directed therapies"
-
28:21
dr. abbey kaler | san antonio breast cancer symposium 2022 | education session
-
22:55
educational sessions: "approving new therapies for early breast cancer"
-
27:09
dr. susan dent | san antonio breast cancer symposium 2022 | educational session
-
25:22
educational sessions: "parp for brca breast cancers"
-
1:05:11
ask the expert: early-stage her2-positive breast cancer with adrienne waks, md
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
10:34
life of a breast cancer warrior. her2 triple positive breast cancer. -pia besmonte
-
1:51:16
dr. bora lim | challenging types of breast cancer | sabcs 2022 | education session
-
33:01
dr. tara kaufmann | san antonio breast cancer symposium | education session
-
1:19:32
dr nyjon eccles - changing the game in breast cancer risk
-
15:50
spotlight session 8 her2 positive breast cancer novel therapies for her2 advanced breast cancer
-
34:23
dr. shanu modi | san antonio breast cancer symposium 2022 | educational session
-
32:18
dr. fumiko chino | san antonio breast cancer symposium 2022 | education session
-
26:59
dr. david rimm | san antonio breast cancer symposium 2022 | general session
-
15:30
dr. sara hurvitz | san antonio breast cancer symposium 2022 | general session
-
16:06
pd8 spotlight session 8 her2 positive breast cancer
-
32:12
education session: "escalating and de-escalation - titrating the right regimen in early stage"
-
15:44
pd8 spotlight session 8 her2 positive breast cancer
-
28:43
stephanie walker & christine hodgdon | san antonio breast cancer symposium 2022 | education session
-
17:19
dr. carmen bergom | san antonio breast cancer symposium 2022 | educational session
-
21:00
gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic